Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Geneva Foundation for Medical Education and Research
Euro Pub
ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Prevalence of steatosis and advanced liver fibrosis in infected patients with HIV Bukavu Provincial Hospital: Preliminary study
International Conference on Digestive Diseases
Patrick de Jesus Ngoma, Rinelle Etinkun, Ghislain Maheshe, Aime Murhula, Lupande David, Yannick Samafundu, Hassan Mwana-Yile, Antoine
Tshimpi, Charles Mbendi, Rene Fiasse and Jeff Kabinda
Provincial General Hospital in Bukavu Reference - Catholic University of Bukavu, Congo
University of Kinshasa, Congo
Cliniques Universitaires Saint-Luc, Belgium
Introduction: Today, there is an increase in the prevalence of fatty liver including in people infected with HIV (PHIV) worldwide.
Objectives: To assess the prevalence and risk factors associated with fatty liver in PHIV tracked Bukavu general reference to provincial
hospital (HPGRB) and to determine the prevalence of advanced liver fibrosis in these patients.
Method: It is a cross-sectional study conducted from March 5 till November 20, 2015 which included 70 patients infected with
HIV as they presented themselves to the HPGRB during the study period. All realized abdominal ultrasound with CHISON i3 or
SONOSCAPE S11 device with a convex probe of 3.5 MHz in addition to laboratory tests to calculate the NAFLD fibrosis score online.
Results: Majority of our study population was aged over 35 years (74.3%) with a predominance of males (58.6%). 10% were
overweight; 20% had a moderate alcohol consumption; 1.4% had diabetes; 38.5% were clinical stage 3 of the WHO and 8.7% in
stage 4. The median CD4 count was 124 (19-618) cells / microliter. 62.9% of patients were treated with AZT+3TC+NVP; 10% in
TNF+3TC+EFV; 7.1% for EFV+TNF+EMTRIC. The prevalence of hepatic steatosis was 59.2% and 14.2% of patients had advanced
liver fibrosis. Factors associated with steatosis were an albumin level of less than 3.5 g/ dL OR=10.8 (1.5 to 264.6) p=0.02; elevation of
alanine aminotransferase (ALT) OR=3.2 (1.1 to 9.8) p=0.02.
Conclusion: Prevalence of hepatic steatosis in our study population was high (59.2%). Hypo albumin and ALT elevation are biological
factors associated with the presence of this steatosis (p=0.02).